What ISIS Medical does

ISIS Medical (operating legal entity Oxylis SAS) is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) specializing in respiratory care for patients with sleep apnea, chronic respiratory insufficiency, neuromuscular and obesity-related hypoventilation syndromes, and ENT/respiratory conditions requiring inhaled therapy. Founded in 2000 by Olivier François, the company has built a federated network of 36 agencies across metropolitan France and overseas territories (DROM-COM), serving more than 200,000 patients cumulatively through four core service lines: sleep apnea treatment (CPAP/PAP therapy), oxygen therapy (concentrators, liquid oxygen, gas cylinders), non-invasive ventilation (NIV), and aerosol therapy. A 24/7 telephone standby service and home visits by qualified technicians support patient onboarding, training, and ongoing adherence.

The technical stack combines physical medical-device provision with a digital care layer: a télésuivi (remote monitoring) program covers 90% of sleep apnea patients, the Apnéassist mobile application drives treatment adherence, and dedicated web portals serve both patients (patients.isismedical.fr) and prescribing physicians (prescripteurs.isismedical.fr) for prescription management, follow-up reporting, and care coordination. Oxylis Formation, a Qualiopi-certified internal training academy, standardizes technical and clinical-educational competencies across the federation. The company is GDPR/CNIL compliant and operates within the French PSAD regulatory framework.

Revenue is generated through managed-services contracts under the French healthcare reimbursement system, with the Sécurité Sociale and complementary health insurers paying for home respiratory care services. Patient acquisition is driven primarily by physician prescriptions (pulmonologists, GPs), supported by the prescriber portal and physician-targeted engagement such as the SFRMS 2024 congress and the Ateliers de ventilation à domicile du Pays Basque training partnership. The company is privately held under parent Oxylis, with no venture capital or institutional investor participation disclosed, and pursues organic growth through geographic coverage, vertical extensions (Isis Diabète subsidiary), and ecosystem partnerships (Adelia Medical, UPSADI membership).

Name

ISIS Medical

Legal name

Oxylis SAS

Website

https://isismedical.fr

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

ISIS Medical is a French home respiratory care provider operating 36 agencies across metropolitan France and overseas territories, serving more than 200,000 patients with sleep apnea (CPAP), oxygen therapy, non-invasive ventilation, and aerosol therapy under the French PSAD reimbursement framework.

Ownership category

akta.pro rank

Product category

Home Respiratory Care Services

NAICS

Home Health Care Services (62161), Health Care and Social Assistance (62)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

• Home respiratory care
• Sleep apnea treatment
• Oxygen therapy
• Non-invasive ventilation
• Aerosol therapy

Headquarters

HQ city

Saint-martin-boulogne

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Home Respiratory Care Services: As a French Prestataire de Santé à Domicile (PSAD), ISIS Medical provides home-based respiratory care services (CPAP for sleep apnea, oxygen therapy, non-invasive ventilation, aerosol therapy) reimbursed by French social security (Sécurité Sociale) and complementary health insurance. Services include equipment provision, home installation, patient training, ongoing monitoring, and maintenance.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

ISIS Medical is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) that delivers home-based respiratory care services to patients with breathing disorders. Its core services include sleep apnea treatment via Positive Airway Pressure (PAP/CPAP) devices, oxygen therapy (concentrators, liquid oxygen, gas cylinders), non-invasive ventilation (NIV/VNI), and aerosol therapy. The company operates through a federation of 36 agencies across France, providing equipment installation, patient training, ongoing remote monitoring, and 24/7 telephone support.

Product overview

ISIS Medical is a French home healthcare provider (Prestataire de Santé à Domicile - PSAD) specializing in respiratory care. The company offers four core treatment services: sleep apnea treatment (PPC/PAP therapy), non-invasive ventilation (VNI), oxygen therapy, and aerosol therapy. These services are delivered through a network of 36 agencies across France, serving over 200,000 patients. The product portfolio includes both clinical care services and digital tools: the Apnéassist mobile app for patient remote monitoring (télésuivi), patient and prescriber web portals, and internal staff training through Oxylis Formation. All services are coordinated with prescribing physicians to ensure quality care and treatment adherence.

Differentiator

Problem solved

Functional benefit

Brands

• Oxylis Formation: Internal training school certified Qualiopi, providing professional development for employees in management, therapeutic education, medical-technical, and administrative functions.

Products and services

• Apnée du sommeil (PPC/PAP Therapy) Sleep apnea treatment using Positive Airway Pressure (PAP) devices with masks for patients with obstructive sleep apnea-hypopnea syndrome (SAHOS). Includes screening tests, diagnosis support, equipment installation, ongoing remote monitoring (télésuivi), and 24/7 support.
• Ventilation (VNI / Non-Invasive Ventilation) Non-invasive ventilation (NIV) at home for patients with respiratory insufficiency, including obesity hypoventilation syndrome (SOH), COPD, and neuromuscular disease-related respiratory failure. Provides ventilators, masks, and ongoing clinical support.
• Oxygénothérapie (Oxygen Therapy) Oxygen therapy for treating respiratory insufficiency, providing oxygen concentrators, liquid oxygen, or gas cylinders. Includes patient education, safety training, and 24/7 on-call support.
• Aérosolthérapie (Aerosol Therapy) Aerosol therapy for administering medication through inhalation via nebulizers (pneumatic, mesh, or ultrasonic generators) for upper and lower respiratory tract conditions.

Quantifiable outcome

• 90% of patients with sleep apnea are remotely monitored (télésuivi)
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Ateliers de ventilation à domicile du Pays BasquecoreStrategic or Co-development Partner · 9 September 2024ISIS Medical is a long-standing partner of the Ventilation at Home Workshops in the Basque Country. Theoretical and practical training on indications, settings, and initiation of non-invasive ventilation (VNI) helps physicians develop their skills throughout the year.
• Adelia MedicalminorStrategic or Co-development PartnerListed as a partner on the ISIS Medical website. Adelia Medical appears to be a related healthcare company in the medical devices or healthcare services space.
• Isis DiabèteminorStrategic or Co-development PartnerISIS Medical partner focused on diabetes care. Part of a related health condition ecosystem, potentially allowing cross-referrals or integrated care for patients with both respiratory and diabetic conditions.
• UPSADI (Union des Prestataires de Santé à Domicile Indépendants)coreStrategic or Co-development PartnerISIS Medical is a member of UPSADI, the Union of Independent Home Health Providers. Through this membership, they advocate for quality and proximity of service with public authorities and participate in shaping healthcare policy for home care.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• VitalAire (Air Liquide Healthcare): VitalAire is the home healthcare division of Air Liquide and the historical leader of the French PSAD market, offering the same home respiratory care services (CPAP, oxygen therapy, ventilation) reimbursed by French social security. It is the most direct large-scale competitor to ISIS Medical's offering and patient base.
• Orkyn': Orkyn' is a major French PSAD originally carved out of Air Liquide and currently PE-backed, providing home respiratory care, perfusion, and nutrition across France. It is a direct competitor in the same French PSAD reimbursement framework and customer segment as ISIS Medical.
• Elivie: Elivie is one of the largest independent French home healthcare providers, delivering respiratory care, perfusion, and insulin-pump therapies under the same LPPR/Sécurité Sociale framework. It is directly comparable in service portfolio, reimbursement model, and target patients.
• SOS Oxygène: SOS Oxygène is an independent French PSAD specializing in home oxygen therapy, CPAP, and ventilation. It competes head-to-head with ISIS Medical across the same indications and French reimbursement system, with a comparable federation-style regional agency model.
• Asten Santé: Asten Santé is a French home healthcare provider covering respiratory care, perfusion, and stomatherapy. It operates under the same PSAD regulatory framework as ISIS Medical and targets the same prescriber base of pulmonologists and GPs.
• LVL Médical: LVL Médical is a French PSAD focused on home oxygen therapy, ventilation, and sleep apnea treatment. It serves the same reimbursed respiratory indications as ISIS Medical and is a peer within the UPSADI ecosystem of independent providers.

Regional players

• Adelia Medical: Adelia Medical is a French medical-device and home-care company listed as a partner on the ISIS Medical website. It operates in adjacent home medical equipment categories and shares the same French regulatory and prescriber context, making it a comparable regional specialist.
• AdaptHealth: AdaptHealth is a US-based home medical equipment provider with a sizable respiratory (CPAP, oxygen, ventilation) business. It does not compete in France but is comparable in business model, patient population, and reimbursement-driven revenue, serving as a useful cross-Atlantic benchmark for scale and unit economics.
• Apria Healthcare (Owens & Minor): Apria Healthcare, now part of Owens & Minor, is a US home medical equipment provider with a strong respiratory franchise (sleep apnea, oxygen, ventilation). Like AdaptHealth, it is a regional benchmark rather than a direct competitor, but its scale and adherence-monitoring approach are directly comparable to ISIS Medical's télé-suivi program.

Broad incumbents

• Linde Healthcare (Linde plc): Linde plc operates a global Healthcare division offering home respiratory services, including home oxygen and sleep therapy, across multiple European markets. It is a broader incumbent with overlapping capabilities but a wider portfolio and international footprint compared with ISIS Medical's France-only focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/isis-m%C3%A9dical
• Facebookfacebook.com/ISISMEDICAL12

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ISIS Medical